Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Karyopharm Therapeutics (KPTI) Receivables - Other (2016)

Historic Receivables - Other for Karyopharm Therapeutics (KPTI) over the last 1 years, with Q4 2016 value amounting to $154000.0.

  • Karyopharm Therapeutics' Receivables - Other changed N/A to $154000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $154000.0, marking a year-over-year change of. This contributed to the annual value of $154000.0 for FY2016, which is N/A changed from last year.
  • As of Q4 2016, Karyopharm Therapeutics' Receivables - Other stood at $154000.0.
  • In the past 5 years, Karyopharm Therapeutics' Receivables - Other ranged from a high of $154000.0 in Q4 2016 and a low of $154000.0 during Q4 2016